All inflammation articles
-
ResearchBiochemistry behind CBD’s anti-inflammatory effects points to new ways to treat inflammation
Cell studies unravel mechanism of action but human studies are needed
-
BusinessMerck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
-
BusinessThe multi-pronged search for Covid-19 treatments
Drugs that block infection or reduce inflammation will complement vaccine protection
-
OpinionDragons of immunology
Anti-inflammatories like dexamethasone are triumphs amid the pitfalls of the immune system
-
OpinionMaking the right call on dexamethasone
The way we do things in research has to change in life or death situations
-
ResearchSelf-illuminating nanoparticles shine a light on cancer
Tumours trigger luminescence for imaging, then production of singlet oxygen to kill cancer cells
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
ResearchBrain chemistry hints at how obesity impairs antidepressants
Histamine released in response to obesity or bacterial toxins prevents benefits from SSRIs – and that drugs that target these inflammatory signals may restore them
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessExpanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
-
ResearchSweetening imaging of sugars to study disease
Whole body labelling of zebrafish sugars will provide new insight into cancer, infection and inflammation
-
NewsGraphene slips deeper into lungs than predicted
Researchers discover that once graphene enters the lungs the immune system has trouble getting rid of it